Eikon Therapeutics, Inc. — Form D
Eikon Therapeutics, Inc. of HAYWARD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-28. The offering totals $400.0M, of which $350.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-28
- Form: D
- Accession: 0001861123-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400.0M
- Amount sold: $350.7M
- Remaining: $49.3M
- Investors: 27
- Date of first sale: 2025-02-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-539574
Issuer
- Name: Eikon Therapeutics, Inc.
- CIK: 0001861123
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3929 POINT EDEN WAY, HAYWARD, CA, 94545
- Phone: 415-865-2050
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Dror M Berman | Director | Hayward, CA |
| Leon M Chen | Director | Hayward, CA |
| Kenneth M Frazier | Director | Hayward, CA |
| Robbie M Huffines | Director | Hayward, CA |
| Robin M Washington | Director | Hayward, CA |
| Joshua M Wolfe | Director | Hayward, CA |
| Leon Chen | Director | Austin, TX |
| Leon Chen | Executive Officer | Austin, TX |
| Adam Goulburn | Director | New York, NY |
| DROR BERMAN | Director | PALO ALTO, CA |
| Dan M Anderson | Executive Officer | Hayward, CA |
| Ashish M Kheterpal | Executive Officer | Hayward, CA |
| Josh M Wolfe | Director | Hayward, CA |
| Russ M Berman | Executive Officer | Hayward, CA |
| Roy M Banes | Executive Officer | Hayward, CA |
| Benjamin M Thorner | Executive Officer | Hayward, CA |
| Alfred M Bowie | Executive Officer | Hayward, CA |
| Barbara M Howes | Executive Officer | Hayward, CA |
| Adam M Goulburn | Director | Hayward, CA |
| James M Tananbaum | Director | Hayward, CA |
| Roger M Perlmutter | Director | Hayward, CA |
| Roger M Perlmutter | Executive Officer | Hayward, CA |
Other filings by this issuer (3)
More